JP2010001264A5 - - Google Patents

Download PDF

Info

Publication number
JP2010001264A5
JP2010001264A5 JP2008162839A JP2008162839A JP2010001264A5 JP 2010001264 A5 JP2010001264 A5 JP 2010001264A5 JP 2008162839 A JP2008162839 A JP 2008162839A JP 2008162839 A JP2008162839 A JP 2008162839A JP 2010001264 A5 JP2010001264 A5 JP 2010001264A5
Authority
JP
Japan
Prior art keywords
itching
preventive
elongation inhibitor
therapeutic agent
nerve elongation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2008162839A
Other languages
Japanese (ja)
Other versions
JP5540474B2 (en
JP2010001264A (en
Filing date
Publication date
Application filed filed Critical
Priority to JP2008162839A priority Critical patent/JP5540474B2/en
Priority claimed from JP2008162839A external-priority patent/JP5540474B2/en
Publication of JP2010001264A publication Critical patent/JP2010001264A/en
Publication of JP2010001264A5 publication Critical patent/JP2010001264A5/ja
Application granted granted Critical
Publication of JP5540474B2 publication Critical patent/JP5540474B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Claims (5)

ゲンノショウコ、サルビア、ヒシュカ、ローズマリー、カサクマ、コウズク、ゴカヒ、ゴシュユ、セイコウ、センレンシ、フクボンシ、ペパーミント及びモクベツシから選ばれる少なくとも１種を含有することを特徴とする神経伸長抑制剤。 A nerve elongation inhibitor characterized by containing at least one selected from Gengosho, Salvia, Hishuka, Rosemary, Casakuma, Kuzukuku, Gokahi, Goshyu, Seiko, Senpai, Fukubonshi, Peppermint and Mokubeshi . ゲンノショウコ、サルビア、ヒシュカ及びローズマリーから選ばれる少なくとも１種を含有することを特徴とする神経伸長抑制剤。 A nerve elongation inhibitor comprising at least one selected from Genkosho, Salvia, Hishuka and Rosemary . 請求項１または２に記載の神経伸長抑制剤を含有することを特徴とする痒みを伴う皮膚疾患における痒みの予防または治療剤。 A preventive or therapeutic agent for itching in skin diseases accompanied by itching, comprising the nerve elongation inhibitor according to claim 1 or 2 . 痒みを伴う皮膚疾患がアトピー性皮膚炎である請求項３に記載の痒みの予防または治療剤。 The preventive or therapeutic agent for itching according to claim 3, wherein the skin disease accompanied by itching is atopic dermatitis. 請求項１または２に記載の神経伸長抑制剤を含有することを特徴とする敏感肌における痒みの予防または治療剤。 A preventive or therapeutic agent for itching in sensitive skin, comprising the nerve elongation inhibitor according to claim 1 or 2 .
JP2008162839A 2008-06-23 2008-06-23 Nerve elongation inhibitor Active JP5540474B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2008162839A JP5540474B2 (en) 2008-06-23 2008-06-23 Nerve elongation inhibitor

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2008162839A JP5540474B2 (en) 2008-06-23 2008-06-23 Nerve elongation inhibitor

Publications (3)

Publication Number Publication Date
JP2010001264A JP2010001264A (en) 2010-01-07
JP2010001264A5 true JP2010001264A5 (en) 2011-06-30
JP5540474B2 JP5540474B2 (en) 2014-07-02

Family

ID=41583279

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008162839A Active JP5540474B2 (en) 2008-06-23 2008-06-23 Nerve elongation inhibitor

Country Status (1)

Country Link
JP (1) JP5540474B2 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5649995B2 (en) * 2011-01-31 2015-01-07 日本メナード化粧品株式会社 Ceramide production promoter
JP2012167023A (en) * 2011-02-09 2012-09-06 Kao Corp Ceramide production promoter, humectant, and skin care preparation for external use
JP2012167022A (en) * 2011-02-09 2012-09-06 Kao Corp Ceramide production promoter, humectant, and skin care preparation for external use
CN102526314A (en) * 2012-01-10 2012-07-04 刘军报 Medicament for treating inguinal hernia and preparation method for medicament
JP5986891B2 (en) * 2012-11-06 2016-09-06 株式会社ファンケル MIF secretion inhibitor
JP6454097B2 (en) * 2013-07-05 2019-01-16 御木本製薬株式会社 Dendritic elongation inhibitor and whitening cosmetic
JP2016204310A (en) * 2015-04-23 2016-12-08 クラシエ製薬株式会社 Neurite outgrowth inhibitor, pain inhibitor, and itch inhibitor
JP7040833B1 (en) * 2021-05-18 2022-03-23 株式会社アイビー化粧品 JAK inhibitor

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3828163B2 (en) * 1994-06-10 2006-10-04 サンスター株式会社 Anti-inflammatory, anti-itch agent
JPH0873342A (en) * 1994-09-05 1996-03-19 Ichimaru Pharcos Co Ltd Skin external preparation or bathing agent containing rubi fructus extract
JPH0873337A (en) * 1994-09-07 1996-03-19 Ogawa Koryo Kk External preparation composition
JPH09194385A (en) * 1996-01-10 1997-07-29 Ichimaru Pharcos Co Ltd Antiallergic agent and preparation for external use for skin or bathing agent blended with the same agent
JP3507635B2 (en) * 1996-09-19 2004-03-15 株式会社コーセー Composition suitable for external use
JPH10279491A (en) * 1997-04-01 1998-10-20 Kao Corp Interleukin 4 production inhibitor
JP3948687B2 (en) * 1997-04-30 2007-07-25 株式会社ノエビア Anti itching lotion
JP3910292B2 (en) * 1998-03-04 2007-04-25 第一三共ヘルスケア株式会社 Anti-inflammatory analgesic for external use
ES2279614T3 (en) * 1998-04-16 2007-08-16 Eurovita A/S NEW SYNERGIC COMPOSITIONS CONTAINING AROMATIC COMPOUNDS AND THERPENOIDS PRESENT IN ALPINIA GALANGA.
JP3920474B2 (en) * 1998-09-25 2007-05-30 花王株式会社 Topical skin preparation
JP4280341B2 (en) * 1998-11-09 2009-06-17 一丸ファルコス株式会社 Cosmetic composition containing moisturizing plant extract
JP2000169383A (en) * 1998-12-07 2000-06-20 Ichimaru Pharcos Co Ltd Antiallergic agent
JP2000319191A (en) * 1999-03-05 2000-11-21 Takeda Chem Ind Ltd Cyclic gmp specific phosphodiesterase inhibitor and sexual dysfunction-improving drug
JP2001226280A (en) * 2000-02-18 2001-08-21 Noevir Co Ltd Staphylococcus aureus enterrotoxin production inhibitor
JP2001288047A (en) * 2000-03-31 2001-10-16 Shiseido Co Ltd Composition for scalp and hair
JP2003012495A (en) * 2001-07-06 2003-01-15 Kanebo Ltd Cosmetic
JP2003286181A (en) * 2002-03-29 2003-10-07 Kobayashi Pharmaceut Co Ltd Improving agent for constitution easily inducing atopic dermatitis
JP2004083551A (en) * 2002-07-02 2004-03-18 Kao Corp Whitening composition
JP2005350412A (en) * 2004-06-11 2005-12-22 Pias Arise Kk Nerve growth factor production inhibitor, and skin care preparation for external use, cosmetic, quasi-medicine, itching-preventing and treating agent, and atopic dermatitis medicine which contain the nerve growth factor production inhibitor
JP2006056902A (en) * 2005-10-24 2006-03-02 Shiseido Co Ltd Medicament for pruritus, chapped skin, sensitive skin and whitening by suppressing production/release of stem cell factor
JP2007186457A (en) * 2006-01-13 2007-07-26 Ichimaru Pharcos Co Ltd Tryptase activity inhibitor and its utilization

Similar Documents

Publication Publication Date Title
JP2010001264A5 (en)
CU20140141A7 (en) 2-ACETAMIDO-5-ARIL-1,2,4-SUBSTITUTED TRIAZOLONES
DOP2007000102A (en) ARILIMIDAZOLONAS AND ARILTRIAZOLONA SUBSTITUTED AS WELL AS ITS USE
JP2008533131A5 (en)
EP2152318A4 (en) Uses and compositions for treatment of psoriasis and crohn's disease
IL213259A0 (en) Composition for the use to treat alzheimer's disease
IL208982B (en) Composition comprising baclofen, or a salt, or derivative, or sustained release formulation thereof, for use in the treatment of alzheimer's disease
MX2010004450A (en) Bicyclic heterocycle derivatives and methods of use thereof.
HRP20220902T3 (en) Compositions and uses for treating multiple sclerosis
JP2014530840A5 (en)
JP2009256391A5 (en)
MY160894A (en) Oligosaccharide composition for treating skin diseases
MX338338B (en) Compositions and methods useful for treatment of respiratory illness.
JP2010222367A5 (en)
CL2008000198A1 (en) COMPOUNDS DERIVED FROM AZACICLOALCANOS, INHIBITORS FROM ESTEAROIL-COENZIMA TO DELTA-9; PHARMACEUTICAL COMPOSITION; AND USE FOR THE TREATMENT OF SICK DISEASES AS TYPE 2 DIABETES, LIPID DISORDER, OBESITY AND ATEROSCLEROSIS.
CL2013001136A1 (en) A phosphodiesterase 7 (pde7) inhibitory agent to be used in the treatment or reduction of the possibility of an addiction; and pharmaceutical composition, unit dosage form and pharmaceutical kit including phosphodiesterase 7 inhibitor (pde7) and an additional therapeutic agent.
IL212568A (en) 1,4-diazepane derivatives, their pharmaceutical compositions and use thereof in the manufacture of medicaments for treating a disease or disorder in a mammal
JP2009519974A5 (en)
CL2008000610A1 (en) COMPOSITION IN THE FORM OF TRANSDERMIC OR TRANSMUCOSE DOSAGE THAT INCLUDES A RELATIONSHIP IN BUPRENORFINE WEIGHT TO NALOXONE BETWEEN 2.1: 1 AND 8: 1, USEFUL FOR THE TREATMENT OF PAIN.
JP2009537554A5 (en)
JP2009520694A5 (en)
HK1145994A1 (en) Use of compounds extracted from momordica charantia l. in the manufacture of medicaments for prevention and treatment of diabetes and obesity
CL2008003027A1 (en) Compounds derived from 5,6-diaryl pyridines substituted at positions 2 and 3; intermediate compounds and their use; pharmaceutical composition; and use to treat and / or prevent psychiatric, metabolic, inflammatory disorders, for the prevention of pain, among other diseases.
JP2012516348A5 (en)
CL2008000982A1 (en) COMPOUNDS DERIVED FROM 5-OXO-ISOXAZOL-CARBOXAMIDA; PREPARATION PROCESS; PHARMACEUTICAL COMPOSITION; PROCEDURE OF PRODUCTION OF THE PHARMACEUTICAL COMPOSITION; AND USE IN THE TREATMENT AND / OR PREVENTION OF ATEROSCLEROTIC DISORDERS, OF METABOLISM OF